Careers
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on the identification of subtle changes in methylation patterns. Nucleix offers a urine test for the monitoring of bladder cancer called Bladder EpiCheck and a blood test for the early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.